Clinical Trial Update: Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia [Phase 2]

View source ↗

Summary

A Phase 2 study comparing NST-1024 to placebo to assess efficacy and safety in subjects with hypertriglyceridemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• NST-1024

Snippet

Sponsor: NorthSea Therapeutics B.V. | Conditions: High Triglycerides | Phase 2 | Status: COMPLETED